Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Stock Short Interest Report for September

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) saw a large increase in short interest in the month of September. As of September 30th, there was short interest totaling 923,789 shares, an increase of 104.0% from the September 15th total of 452,852 shares. Based on an average daily volume of 287,044 shares, the days-to-cover ratio is presently 3.2 days. Currently, 1.5% of the shares of the company are sold short.

Bioceres Crop Solutions Stock Performance

NASDAQ:BIOX opened at $0.29 on Friday. The stock’s fifty day moving average is $0.39 and its 200 day moving average is $0.42. Bioceres Crop Solutions has a fifty-two week low of $0.28 and a fifty-two week high of $2.19. The company has a debt-to-equity ratio of 0.94, a quick ratio of 0.63 and a current ratio of 0.81.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its quarterly earnings results on Tuesday, September 15th. The company reported ($0.39) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.33). Bioceres Crop Solutions had a negative return on equity of 39.11% and a negative net margin of 94.76%. The company had revenue of $55.90 million during the quarter, compared to the consensus estimate of $79.00 million.

Hedge Funds Weigh In On Bioceres Crop Solutions

An institutional investor recently raised its position in Bioceres Crop Solutions stock. Ardsley Advisory Partners LP raised its position in Bioceres Crop Solutions Corp. (NASDAQ:BIOX) by 691.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 475,000 shares of the company’s stock after purchasing an additional 415,000 shares during the quarter. Ardsley Advisory Partners LP owned 0.75% of Bioceres Crop Solutions worth $622,000 as of its most recent SEC filing. 17.68% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Bioceres Crop Solutions in a report on Friday, October 9th. Two research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Bioceres Crop Solutions currently has a consensus rating of “Reduce” and a consensus target price of $2.00.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) is an Argentina-based agricultural biotechnology company focused on developing technologies that improve crop productivity, resilience and sustainability. Its offerings include genetically enhanced seeds, biological crop inputs, seed treatments, biostimulants, fertilizers and crop protection products designed for use across major field crops.

The company is best known for its HB4 technology, a drought-tolerance trait developed for wheat and soybeans.